Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications
Medical Sciences · 2026
DOI: 10.3390/medsci14020166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Diana Nikolova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Aleksandrovska University Hospital, Medical University of Sofia, 1431 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Neopterin, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Autonomic Nervous System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union- NextGenerationEU.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Chronic low-grade inflammation plays a central role in the pathogenesis of type 2 diabetes (T2DM) and its complications. Neopterin, a marker of macrophage activation and Th1-mediated immune response, has been associated with cardiovascular disease and metabolic disorders. However, its relationship with diabetic autonomic neuropathy remains insufficiently investigated.
Methods
We conducted a cross-sectional study including 129 participants (93 with T2DM and 36 with obesity without carbohydrate disturbances). Clinical, anthropometric, and biochemical assessments were performed. Cardiovascular autonomic neuropathy was evaluated using Ewing cardiovascular reflex tests and sudomotor dysfunction scoring. Neopterin concentrations were measured in serum. Correlation, ROC, and logistic regression analyses were performed.
Results
Neopterin levels were not significantly different between T2DM and obesity groups. No differences were observed in patients with versus without peripheral neuropathy, nephropathy, or retinopathy. However, neopterin levels were significantly higher in individuals with cardiovascular autonomic neuropathy (p = 0.013). Neopterin correlated with cardiovascular autonomic neuropathy score, sudomotor dysfunction, fasting glucose, fasting insulin, and HOMA-IR. It showed a moderate negative monotonic correlation with eGFR (Spearman’s rho = −0.41, p< 0.001). In multivariable logistic regression adjusted for age, HbA1c, BMI, eGFR, and diabetes duration, each 1-SD increase in neopterin was associated with 2.67-fold higher odds of cardiovascular autonomic neuropathy (95% CI 1.21–5.89; p = 0.015).
Conclusions
Circulating neopterin is independently associated with cardiovascular autonomic neuropathy in T2DM but not with classical microvascular complications. These findings suggest a potential role of immune-mediated mechanisms in the pathogenesis of diabetic cardiovascular autonomic neuropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Aleksandrovska University Hospital, Medical University of Sofia, 1431 Sofia, Bulgaria.
- Department of Clinical Laboratory, Aleksandrovska University Hospital, Medical University of Sofia, 1431 Sofia, Bulgaria.
ORCID-Profile: Diana Nikolova, Julieta Hristova, Antoaneta Trifonova Gateva
Förderung
- European Union- NextGenerationEU
Zitieren
APA
Nikolova, D., Kamenov, Z., Hristova, J., & Gateva, A. T. (2026). Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications. Medical Sciences. https://doi.org/10.3390/medsci14020166
Vancouver
Nikolova D, Kamenov Z, Hristova J, Gateva AT. Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications. Medical Sciences. 2026. doi:10.3390/medsci14020166
BibTeX
@article{Nikolova2026,
author = {Nikolova, Diana and Kamenov, Zdravko and Hristova, Julieta and Gateva, Antoaneta Trifonova},
title = {Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications},
journal = {Medical Sciences},
year = {2026},
doi = {10.3390/medsci14020166}
}
EUVIMED